- This Week at FDA: FDA staff raise concerns about peptide conflicts, top Democrat wants DOGE investigation, and moreWelcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This wee…raps · 11d ago↗ source
- Mirador unveils part of pipeline with drug from Kira to rival TavneosMirador Therapeutics, the secretive immune disease biotech with more than $650 million in VC funding, is finally revealing a piece of its pipeline. The San Diego biotech said Thursday it reached a…Endpoints · 12d ago↗ source
- Lilly to buy AtaiBeckley for $2.8B, further validating psychedelicsThe latest in a prolific streak of buyouts by Lilly is the strongest sign yet that large pharmaceutical companies may finally be embracing a long-dismissed field of research.